51672-4060 : Amcinonide 1 mg/g Topical Ointment
NDC: | 51672-4060 |
Labeler: | Taro Pharmaceuticals U.S.a., Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Amcinonide |
Dosage Form: | Topical Ointment |
Application #: | ANDA076367 |
Rev. Date: |
NDC Package Codes:
- 51672-4060-1: 1 TUBE IN 1 CARTON (51672‑4060‑1) > 15 G IN 1 TUBE
- 51672-4060-2: 1 TUBE IN 1 CARTON (51672‑4060‑2) > 30 G IN 1 TUBE
- 51672-4060-3: 1 TUBE IN 1 CARTON (51672‑4060‑3) > 60 G IN 1 TUBE
Active Ingredients:
- Amcinonide
Dosage Strength:
- 1 mg/g
Pharmaceutical Classes:
- Corticosteroid [EPC]
- Corticosteroid Hormone Receptor Agonists [MoA]
Related Products:
Based on records with the same trade name.- 51672-4054 Amcinonide 1 mg/g Topical Cream by Taro Pharmaceuticals U.S.a., Inc.
- 0168-0278 Amcinonide 1 mg/g Topical Cream by E. Fougera & Co. a Division of Fougera Pharmaceuticals Inc.
- 0168-0279 Amcinonide 1 mg/g Topical Ointment by E. Fougera & Co. a Division of Fougera Pharmaceuticals Inc.
- 0168-0280 Amcinonide 1 mg/g Topical Lotion by E. Fougera & Co. a Division of Fougera Pharmaceuticals Inc.
- 73308-407 Amcinonide 1 mg/g Topical Ointment by Ayurax, LLC
- 74157-006 Amcinonide 1 mg/g Topical Cream by Ina Pharmaceutics Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 51672-4057Next: 51672-4061 >
Related Discussions:
Amcinonide prescription
My local pharmacies do not have this med. I have a prescription and cannot get it filled. When will it be available? ## ... 2 replies
My local pharmacies do not have this med. I have a prescription and cannot get it filled. When will it be available? ## ... 2 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.